乙型肝炎病毒携带孕妇乳汁和血清 HBV DNA载量与婴儿感染率的关系分析

doi:10.3969/j.issn.1672-5069.2017.04.027

Abstract

Ma Yong.. Prevalence of hepatitis B infection in infants with hepatitis B virus-carrying mothers[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 486-487.

[1] 孙庆丰,吕勇,徐道振,等. 乙型肝炎病毒e抗原及DNA载量对慢性乙型重型肝炎预后的影响.中华肝脏病杂志,2015,14（6）:410-413.
[2] 方宏罡,董秀鹏. 慢性乙型肝炎白介素18及其结合蛋白与乙型肝炎病毒DNA载量的相关性.中国老年学杂志,2015,34（14）:3953-3955.
[3] 张先华. 替比夫定阻断血清HBV高载量孕妇母婴传播疗效及其安全性观察. 实用肝脏病杂志,2015,18（4）:411-412.
[4] 张荣莲,罗颖,谢婧娴,等. HBV父婴垂直传播水平与HBV DNA载量的相关研究. 中华流行病学杂志,2014,31（2）:159-162.
[5] 张荣莲,王梅颖,陈起燕,等. HBV感染者精液HBV DNA载量对子代垂直传播的影响. 中华流行病学杂志,2014,35（2）:117-120.
[6] 曹璟宜,杨二娜,于爱萍,等. 乙型肝炎病毒感染产妇血清病毒载量和e抗原表达与乳汁中病毒载量的相关性研究.中华传染病杂志,2016,34（10）:582-585.
[7] 何佳英,张迎华,张永乐,等. 乙型肝炎病毒感染产妇乳汁中乙型肝炎病毒DNA载量对母乳喂养的指导意义.中华预防医学杂志,2014,45（11）:1004-1006.
[8] 彭建平,孙克伟,伍玉南,等. 慢性乙型肝炎患者外周血树突状细胞HBV DNA载量与其功能的关系.世界华人消化杂志,2013,16（31）:3556-3560.
[9] 张荣莲,王梅颖,陈起燕,等. 父母双方乙型肝炎病毒感染垂直传播的危险因素研究. 中华流行病学杂志,2013,34（12）:1283-1287.
[10] 王翠敏,韩国荣,江红秀,等. 不同联合免疫策略对乙型肝炎病毒高载量孕妇所生婴儿抗-HBs水平的影响.中华肝脏病杂志,2015,23（7）:493-497.
[11] 张荣莲,陈起燕,谢婧娴,等.乙型肝炎病毒父婴垂直传播的危险因素分析.中华妇产科杂志,2013,44（11）:805-808.
[12] Zhang L,Gui X,Fan J,et al. Breast feeding and immunoprophylaxis efficacy of mother-to-child transmission of hepatitis B virus. J Matern Fet Neonat Med,2014,27（1/2）:182-186.
[13] Khamduang W,Ngo GH,Gaudy GC,et al. Prevalence,risk factors,and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Diss,2013,56（12）:1704-1712.
[14] Khamduang W,Gaudy GC,Ngo GH,et al. Analysis of residual perinatal transmission of hepatitis B virus （HBV） and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring. J Clin Virol,2013,58（2）:415-421.

Prevalence of hepatitis B infection in infants with hepatitis B virus-carrying mothers

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 9

Recommended Articles

Metrics

Comments

[1]	Weng Yerui, Fu Aizhen. Investigation of milk HBV DNA in pregnant women with chronic HBV infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 457-458.
[2]	Zhang Jing, Chen Rui, Xu Na, et al. Serological survey of anti-hepatitis B surface antigen antibody in individuals in eight districts of Xi'an, Shaanxi Province [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 279-280.
[3]	Xu Chengfu, Li Youming. Hyperuricemia in patients with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 260-262.
[4]	Zhao Heping, Hou Tianqing, Ding Baohua, Zhang Ziran, Li jing, Liu Xiaolei, ShaoDandan, Guo Shimin. Efficacy of entecavir and immunotherapy in treatment of hepatitis B virus carriers [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 25-28.
[5]	Chen Xuefu， Chen Xiaoping， Ma Xiaojun， et al.. Liver pathologic changes in chronic Hepatitis B patients with mildly elevated serum alanine aminotransferase levels after two-year followed-up [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 594-597.
[6]	Lu Dan，Duan Zhijun. Prevalence of liver disease-related antibodies in patients with acute drug-induced liver injury and its clinical significance [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 504-507.
[7]	Wang Wei, Yang Li, Gao Hengbo, et al. Changes of T lymphocyte subsets in chronic hepatitis B virus carriers with different serum HBV DNA loads [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 74-75.
[8]	Feng Zhenhua, Zhang Shu, Liu Jingli. Virologic determinants of postpartum spontaneous HBeAg and/or HBsAg seroclearance or seroconversion in pregnant women who are chronic hepatitis B virus carriers [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(4): 376-380.
[9]	Wang Chunxia, Mai Yunping, Sha Weihong, et al.. Prevalence and risk factors of non-alcoholic fatty liver disease in checked-up individuals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(4): 289-290.